MedPath

Home-based treatment program to improve quality of life and swallowing function in head and neck cancer patients with chronic swallowing disorders after treatment with chemoradiotherapy

Not Applicable
Conditions
Chronic radiation-associated dysphagia in head and neck cancer survivors
Signs and Symptoms
Dysphagia
Registration Number
ISRCTN57028065
Lead Sponsor
Antwerp University Hospital
Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36273210/ (added 24/10/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
105
Inclusion Criteria

1. Patients with a history of head and neck cancer treated with radiotherapy or chemoradiotherapy
2. Diagnosis of C-RAD, present for at least 3 months, based on the EAT-10 (score =3) and/or FOIS (max level 6 out of 7)
3. Eligible tumour sites: oral cavity, oropharynx, larynx, hypopharynx and nasopharynx
4. At least 6 months post-treatment

Exclusion Criteria

1. History of major surgery within the head and neck region
2. Recurrent carcinoma in the head and neck region
3. Neurological history that might adversely affect cognition, muscle strength in the head and neck region or swallowing function
4. Dysphagia prior to CRT
5. Intensive swallowing therapy (> once per week) in the last 6 months
6. Complete dependency on tube feeding during more than 1 year
7. Severe frailty or worse following the Clinical Frailty Scale (CFS) (=7)
8. Related to HD-tDCS: presence of implanted metal or electronic medical devices in the brain or other sites in the body (e.g. deep brain stimulator, cochlear Implant, pacemaker) except for dental implants, history of migraine, epilepsy, brain damage (stroke) or head trauma followed by impairment or consciousness, skin problems (e.g. dermatitis, psoriasis) and use of medication that interferes with non-invasive brain stimulation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Functional oral intake based on scores from the Functional Oral Intake Scale (FOIS) measured after 8 weeks of training
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath